Camrelizumab plus TP: Clinical Trials

1 trial of Camrelizumab plus TP, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Camrelizumab plus TP: new trials by email Literature Review of Camrelizumab plus TP trials Research Report on Camrelizumab plus TP

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma
Camrelizumab plus TP, TP - Oral Squamous Cell Carcinoma
Phase 3UnknownHospital of Stomatology, Wuhan University3092023-11-212024-04-02

Conditions studied

Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Hospital of Stomatology, Wuhan University (1)

Countries

China (1)

Top investigators

Gang Chen, M.D. (1)